reviewDrug Discovery TodayOct 1, 2002Closed access

Structure-based virtual screening: an overview

PDPaul D. Lyne

AstraZeneca (South Korea) · AstraZeneca (United States) · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

662
total citations
FWCI
16.45
Percentile
100%
References
77
Citations per year

Authors

1

Topics & keywords

Topics
Keywords
  • Virtual screening
  • Computer science
  • Strengths and weaknesses
  • Data science
  • Drug discovery
  • Process (computing)
  • Risk analysis (engineering)
  • Quality (philosophy)
No related works found for this paper.